These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9453598)

  • 1. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep.
    Simmons CP; Dunstan SJ; Tachedjian M; Krywult J; Hodgson AL; Strugnell RA
    Infect Immun; 1998 Feb; 66(2):474-9. PubMed ID: 9453598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis.
    Simmons CP; Hodgson AL; Strugnell RA
    Infect Immun; 1997 Aug; 65(8):3048-56. PubMed ID: 9234753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.
    Hodgson AL; Tachedjian M; Corner LA; Radford AJ
    Infect Immun; 1994 Dec; 62(12):5275-80. PubMed ID: 7960105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.
    Hodgson AL; Carter K; Tachedjian M; Krywult J; Corner LA; McColl M; Cameron A
    Vaccine; 1999 Feb; 17(7-8):802-8. PubMed ID: 10067685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Silva MTO; Bezerra FSB; de Pinho RB; Begnini KR; Seixas FK; Collares T; Portela RD; Azevedo V; Dellagostin O; Borsuk S
    Vaccine; 2018 Jan; 36(1):74-83. PubMed ID: 29174312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis.
    Fontaine MC; Baird G; Connor KM; Rudge K; Sales J; Donachie W
    Vaccine; 2006 Aug; 24(33-34):5986-96. PubMed ID: 16806606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A description of genes of Corynebacterium pseudotuberculosis useful in diagnostics and vaccine applications.
    D'Afonseca V; Moraes PM; Dorella FA; Pacheco LG; Meyer R; Portela RW; Miyoshi A; Azevedo V
    Genet Mol Res; 2008 Mar; 7(1):252-60. PubMed ID: 18551390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel antigen from Corynebacterium pseudotuberculosis that protects sheep against caseous lymphadenitis.
    Walker J; Jackson HJ; Eggleton DG; Meeusen EN; Wilson MJ; Brandon MR
    Infect Immun; 1994 Jun; 62(6):2562-7. PubMed ID: 8188379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.
    Ribeiro D; Rocha Fde S; Leite KM; Soares Sde C; Silva A; Portela RW; Meyer R; Miyoshi A; Oliveira SC; Azevedo V; Dorella FA
    Vet Res; 2014 Mar; 45(1):28. PubMed ID: 24597857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines.
    Eggleton DG; Haynes JA; Middleton HD; Cox JC
    Aust Vet J; 1991 Oct; 68(10):322-5. PubMed ID: 1755783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
    Droppa-Almeida D; Vivas WL; Silva KK; Rezende AF; Simionatto S; Meyer R; Lima-Verde IB; Delagostin O; Borsuk S; Padilha FF
    Vaccine; 2016 Feb; 34(8):1091-6. PubMed ID: 26796140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine gene expression in sheep following experimental infection with various strains of Corynebacterium pseudotuberculosis differing in virulence.
    Pépin M; Seow HF; Corner L; Rothel JS; Hodgson AL; Wood PR
    Vet Res; 1997; 28(2):149-63. PubMed ID: 9112737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A field trial to evaluate a whole cell vaccine for the prevention of caseous lymphadenitis in sheep and goat flocks.
    Menzies PI; Muckle CA; Brogden KA; Robinson L
    Can J Vet Res; 1991 Oct; 55(4):362-6. PubMed ID: 1790493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunisation against ovine caseous lymphadenitis: efficacy of monocomponent Corynebacterium pseudotuberculosis toxoid vaccine and combined clostridial-corynebacterial vaccines.
    Eggleton DG; Doidge CV; Middleton HD; Minty DW
    Aust Vet J; 1991 Oct; 68(10):320-1. PubMed ID: 1755782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired immunity after primary caseous lymphadenitis in sheep.
    Pépin M; Pardon P; Marly J; Lantier F; Arrigo JL
    Am J Vet Res; 1993 Jun; 54(6):873-7. PubMed ID: 8323055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.
    de Pinho RB; de Oliveira Silva MT; Bezerra FSB; Borsuk S
    Appl Microbiol Biotechnol; 2021 Mar; 105(6):2287-2296. PubMed ID: 33651132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corynebacterium pseudotuberculosis secreted antigen-induced specific gamma-interferon production by peripheral blood leukocytes: potential diagnostic marker for caseous lymphadenitis in sheep and goats.
    Rebouças MF; Portela RW; Lima DD; Loureiro D; Bastos BL; Moura-Costa LF; Vale VL; Miyoshi A; Azevedo V; Meyer R
    J Vet Diagn Invest; 2011 Mar; 23(2):213-20. PubMed ID: 21398439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep.
    Chaplin PJ; De Rose R; Boyle JS; McWaters P; Kelly J; Tennent JM; Lew AM; Scheerlinck JP
    Infect Immun; 1999 Dec; 67(12):6434-8. PubMed ID: 10569760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a commercially available vaccine against Corynebacterium pseudotuberculosis for use in sheep.
    Piontkowski MD; Shivvers DW
    J Am Vet Med Assoc; 1998 Jun; 212(11):1765-8. PubMed ID: 9621886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis.
    Moura-Costa LF; Bahia RC; Carminati R; Vale VL; Paule BJ; Portela RW; Freire SM; Nascimento I; Schaer R; Barreto LM; Meyer R
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):131-41. PubMed ID: 18752855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.